These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36791487)

  • 21. Sustained Mood Improvement with Laughing Gas Exposure (SMILE): Study protocol for a randomized placebo-controlled pilot trial of nitrous oxide for treatment-resistant depression.
    Ladha KS; Lee J; Mattina GF; Pazmino-Canizares J; Wijeysundera DN; Gholamali Nezhad F; Philip K; Tassone VK; Adamsahib F; Bhat V;
    PLoS One; 2024; 19(1):e0297330. PubMed ID: 38241247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study.
    Desmidt T; Dujardin PA; Andersson F; Brizard B; Réméniéras JP; Gissot V; Arlicot N; Barantin L; Espitalier F; Belzung C; Tanti A; Robert G; Bulteau S; Gallet Q; Kazour F; Cognet S; Camus V; El-Hage W; Poupin P; Karim HT
    Mol Psychiatry; 2023 Sep; 28(9):3900-3908. PubMed ID: 37592013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression.
    Moderie C; Nuñez N; Fielding A; Comai S; Gobbi G
    Int J Neuropsychopharmacol; 2022 Jun; 25(6):479-488. PubMed ID: 35167671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Husain MI; Chaudhry IB; Khoso AB; Kiran T; Khan N; Ahmad F; Hodsoll J; Husain MO; Naqvi HA; Nizami AT; Chaudhry N; Khan HA; Minhas F; Meyer JH; Ansari MA; Mulsant BH; Husain N; Young AH
    JAMA Netw Open; 2023 Feb; 6(2):e230147. PubMed ID: 36808239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression.
    Jiang J; Wang Z; Dong Y; Yang Y; Ng CH; Ma S; Xu Y; Hu H; Hu S
    Medicine (Baltimore); 2019 Aug; 98(31):e16674. PubMed ID: 31374046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A follow-up study on features of sensory gating P50 in treatment-resistant depression patients.
    Wang Y; Fang YR; Chen XS; Chen J; Wu ZG; Yuan CM; Yi ZH; Hong W; Zhang C; Cao L
    Chin Med J (Engl); 2009 Dec; 122(24):2956-60. PubMed ID: 20137481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD).
    Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2019 May; 251():162-169. PubMed ID: 30925267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct patterns of functional brain network integration between treatment-resistant depression and non treatment-resistant depression: A resting-state functional magnetic resonance imaging study.
    Sun J; Ma Y; Guo C; Du Z; Chen L; Wang Z; Li X; Xu K; Luo Y; Hong Y; Yu X; Xiao X; Fang J; Lu J
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110621. PubMed ID: 36031163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.
    Bottemanne H; Morlaas O; Claret A; Sharot T; Fossati P; Schmidt L
    JAMA Psychiatry; 2022 Nov; 79(11):1124-1132. PubMed ID: 36169969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    J Affect Disord; 2018 Jan; 225():709-714. PubMed ID: 28922734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.
    Hudgens S; Floden L; Blackowicz M; Jamieson C; Popova V; Fedgchin M; Drevets WC; Cooper K; Lane R; Singh J
    J Affect Disord; 2021 Feb; 281():767-775. PubMed ID: 33261932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant Effects of Electroconvulsive Therapy Unrelated to the Brain's Functional Network Connectivity alterations at an Individual Level.
    Chen GD; Ji F; Li GY; Lyu BX; Hu W; Zhuo CJ
    Chin Med J (Engl); 2017 Feb; 130(4):414-419. PubMed ID: 28218214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No antidepressant effects of low intensity transcranial pulsed electromagnetic fields for treatment resistant depression.
    van Belkum SM; de Boer MK; Opmeer EM; Kortekaas R; Mulder T; Woonings F; Hoenders HJR; Kamphuis H; Aleman A; Schoevers RA
    J Affect Disord; 2021 Nov; 294():679-685. PubMed ID: 34333176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study.
    Chen MH; Lin WC; Tu PC; Li CT; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2019 Dec; 259():15-20. PubMed ID: 31437695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden and the challenge of treatment-resistant depression.
    Touloumis C
    Psychiatriki; 2021 Dec; 32(Supplement I):11-14. PubMed ID: 34990376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging evidence for antidepressant actions of anesthetic agents.
    Tadler SC; Mickey BJ
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):439-445. PubMed ID: 29794854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.